A new study, led by Dr. Apar Gupta, assistant professor of radiation oncology, may help women and their physicians narrow down the treatment choices for DCIS.
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
Congratulations to the 2021 recipients of Conquer Cancer/ASCO awards for young investigators who are working on innovative research projects aimed at advancing cancer care and treatment.
A new study finds that cervical cancer screening tests are frequently overused among commercially insured women with average risk of developing cancer.
As a skin cancer specialist, Dr. Larisa Geskin has devoted her career to treating patients and promoting awareness about cancer prevention and the importance of daily sunscreen usage.
A new study by HICCC members shows that the presence of a rare and previously unknown type of immune cell in kidney tumors can predict which patients are likely to have cancer recur after surgery.
The HICCC joins fellow NCI cancer centers to urge the public to complete their HPV vaccinations, and help boost vaccination rates for HPV, which have decreased during the pandemic.